I alt 453 personer modtog enten den ikke- stabiliserede gul feber- vaccine eller en konkurrerende gul feber - vaccine, og serokonverteringsrate og bivirkningsprofil for de to vacciner svarede til hinanden.
A total of 453 subjects received either the non-stabilised yellow fever vaccine or a competitive yellow fever vaccine and the seroconversion rate and adverse event profile was similar.